Search

everythinglearnresearchcommunity

for

Search:↓

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Nanoparticles sized between 470 and 750 nm are best for delivering substances like caffeine into hair follicles for absorption.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Skin irritants can promote hair growth by affecting specific skin proteins.

A 10-year-old boy had the earliest reported case of hair that became progressively kinkier but eventually returned to normal on its own.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

JAK inhibitors offer new hope for treating severe alopecia areata.

Akt2 protein is essential for normal cell division in early mouse embryos.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Shampoo with heat-killed Lacticaseibacillus paracasei GMNL-653 improves scalp health and hair growth by changing scalp bacteria.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Heat-killed Enterococcus faecalis EF-2001 may promote hair growth and transition hair follicles to the growth phase.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

The enzyme pyruvate kinase M2 helps hair regrowth and could be a potential treatment for hair loss.

Activating PKM2 and Wnt/β-catenin signaling together can potentially enhance hair growth and could be a treatment for hair loss.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

JAK inhibitors show promise for treating various skin diseases.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

JAK inhibitors show promise as a future treatment for hair loss.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.